MyFinsight
Home
Blog
About
Net income
$14,682K
(-75.77%↓ Y/Y)
Depreciation and
amortization expense
$10,242K
(-20.41%↓ Y/Y)
Proceeds from issuance of
common stock upon...
$1,009K
(-88.57%↓ Y/Y)
Stock-based compensation
expense
$8,606K
(-53.05%↓ Y/Y)
Non-cash interest
expense
$4,639K
Deferred taxes
$3,799K
Accounts payable
$1,598K
(489.76%↑ Y/Y)
Non-cash operating lease
expense
$619K
Deferred revenue
$185K
(196.35%↑ Y/Y)
Unrealized foreign
currency transaction...
-$166K
(-111.27%↓ Y/Y)
Net cash provided by
operating activities
$17,309K
(-80.50%↓ Y/Y)
Net cash provided by
financing activities
$970K
(-90.41%↓ Y/Y)
Canceled cashflow
$27,227K
Canceled cashflow
$39K
Net increase in cash
and restricted cash
$10,936K
(-82.89%↓ Y/Y)
Canceled cashflow
$7,343K
Accounts receivable
$13,428K
(102.96%↑ Y/Y)
Inventory
$6,350K
(211.07%↑ Y/Y)
Prepaid expenses and
other current assets
$4,349K
(502.31%↑ Y/Y)
Accrued expenses and
other current...
-$2,230K
(7.58%↑ Y/Y)
Operating lease
liabilities
-$783K
(43.18%↑ Y/Y)
Other non-current
assets
$87K
(2075.00%↑ Y/Y)
Tax withholding
payments related to net...
$39K
Net cash used in
investing activities
-$7,092K
(80.36%↑ Y/Y)
Effect of exchange rate
changes on cash and...
-$251K
(-121.51%↓ Y/Y)
Purchases of property,
plant and equipment
$7,092K
(-80.36%↓ Y/Y)
Back
Back
Cash Flow
TransMedics Group, Inc. (TMDX)
TransMedics Group, Inc. (TMDX)
source: myfinsight.com